AAPACN is dedicated to supporting post-acute care nurses provide quality care.

MDS Updates and Regulatory Considerations: Antipsychotics – March 30, 2023

Members: $23 |  Non-members: $46
Continuing Education: 1.0 CE hour
Recording Date: March 30, 2023
Duration: 60 minutes
Speakers: Denise Winzeler, RN, BSN, LNHA, DNS-MT, QCP-MT, and Jessie McGill, RN, BSN, RAC-MT, RAC-MTA

MDS changes coming this October include the expansion of the pharmacological classes of medications in section N and a new column for indication of use for each drug type. These changes are directly connected to the federal regulations for unnecessary medications and antipsychotic use, and to the new schizophrenia audit. During this 60-minute webinar, AAPACN Curriculum Development Specialists, Denise Winzeler, RN, BSN, LNHA, DNS-MT, QCP-MT, and Jessie McGill, RN, RAC-MT, RAC-MTA, will discuss how to prepare for success with these updates by establishing systematic approaches to monitor appropriate medication use, and ensure accurate MDS coding and sound documentation to support diagnoses.

After participating in this webinar, learners will be able to:

• Identify the new medication classes and indication for use items that will be added to the MDS, effective Oct. 1, 2023
• Recognize the connection between coding indication of use of medications and current regulatory requirements
• Implement a systemic approach to maintain compliance with regulatory requirements